Related Articles
Differential expression of the Na+/I‑ symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues
Inhibiting β-catenin expression promotes efficiency of radioiodine treatment in aggressive follicular thyroid cancer cells probably through mediating NIS localization
LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway
Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer
Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography